Incidence and Onset of Cytomegalovirus Infection in Kidney Transplant Recipients: 3 Months Compared to 6 Months of Prophylaxis

被引:0
|
作者
West-Thielke, P. [1 ]
Schmiedeskamp, M. [1 ]
Aggarwal, N. [1 ]
Thielke, J. [1 ]
Oberholzer, J. [1 ]
Benedetti, E. [1 ]
机构
[1] Univ Illinois, Chicago, IL 60680 USA
关键词
D O I
暂无
中图分类号
R61 [外科手术学];
学科分类号
摘要
1547
引用
收藏
页码:480 / 480
页数:1
相关论文
共 50 条
  • [31] Risk Factors for Breakthrough Cytomegalovirus Infection While on Prophylaxis in Kidney and Pancreas Transplant Recipients
    Moody, K.
    Byrns, J.
    Gommer, J.
    Yang, Z.
    Erkanli, A.
    Harris, M.
    AMERICAN JOURNAL OF TRANSPLANTATION, 2023, 23 (06) : S1112 - S1113
  • [32] THE INCIDENCE OF CYTOMEGALOVIRUS-INFECTION IN KIDNEY RECIPIENTS
    CUHADAROGLU, S
    TOKYAY, R
    VELIDEDEOGLU, E
    HABERAL, M
    TRANSPLANTATION PROCEEDINGS, 1992, 24 (05) : 1924 - 1925
  • [33] Impacts of Interleukin-18 Polymorphisms on the Incidence of Delayed-Onset Cytomegalovirus Infection in a Cohort of Kidney Transplant Recipients
    Perez-Flores, Isabel
    Luis Santiago, Jose
    Fernandez-Perez, Cristina
    Urcelay, Elena
    Moreno de la Higuera, Maria Angeles
    Calvo Romero, Natividad
    Rodriguez Cubillo, Beatriz
    Isabel Sanchez-Fructuoso, Ana
    OPEN FORUM INFECTIOUS DISEASES, 2019, 6 (09):
  • [34] Incidence and Risk Factors for Leukopenia in Kidney Transplant Recipients Receiving Valganciclovir for Cytomegalovirus Prophylaxis.
    Liang, C.
    Famure, O.
    Li, Y.
    Kim, J.
    AMERICAN JOURNAL OF TRANSPLANTATION, 2013, 13 : 319 - 319
  • [35] Cytomegalovirus prevention in high risk lung transplant recipients: Comparison of 3 months vs. 12 months valganciclovir therapy
    Jaksch, P. T. H.
    Zweytick, B.
    Lang, G.
    Hoda, A.
    Keplinger, M.
    Gaugg, M.
    Klepetko, W.
    JOURNAL OF HEART AND LUNG TRANSPLANTATION, 2008, 27 (02): : S103 - S103
  • [36] Risk Factors for Late-Onset Cytomegalovirus Infection or Disease in Kidney Transplant Recipients
    Jamal, Alainna J.
    Husain, Shahid
    Li, Yanhong
    Famure, Olusegun
    Kim, S. Joseph
    TRANSPLANTATION, 2014, 97 (05) : 569 - 575
  • [37] Bimonthly viral monitoring for late-onset cytomegalovirus infection in kidney transplant recipients
    Melgarejo, Ivy
    Jorgensen, Dana
    Hariharan, Sundaram
    Puttarajappa, Chethan M.
    CLINICAL TRANSPLANTATION, 2021, 35 (05)
  • [38] The Role of Secondary Cytomegalovirus Prophylaxis for Kidney and Liver Transplant Recipients
    Sullivan, Timothy
    Brodginski, Alison
    Patel, Gopi
    Huprikar, Shirish
    TRANSPLANTATION, 2015, 99 (04) : 855 - 859
  • [39] Determinants of Mortality at 6 Months in Liver Transplant Recipients
    Madrid, Guillermo
    Zuluaga, Andres
    Montoya, Ana
    Ferrer, Leopoldo
    Ceballos, Cesar
    Triana, Carlos
    Amaya, Oswaldo
    Garzon, Cristian
    Parada-Marquez, Juan Fernando
    ANESTHESIA AND ANALGESIA, 2024, 139 (06):
  • [40] Valganciclovir prophylaxis for cytomegalovirus infection in pediatric kidney transplant recipients: a single-center experience
    Iida, Takaya
    Miura, Kenichiro
    Ban, Hideki
    Ando, Taro
    Shirai, Yoko
    Ishiwa, Sho
    Shiratori, Atsutoshi
    Kaneko, Naoto
    Yabuuchi, Tomoo
    Ishizuka, Kiyonobu
    Takaiwa, Masanori
    Suyama, Kazuhide
    Hisano, Masataka
    Hattori, Motoshi
    CLINICAL AND EXPERIMENTAL NEPHROLOGY, 2021, 25 (05) : 531 - 536